Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 80701-80750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05664737
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
PHASE2
Recruiting
249 participants
Started: Dec 9, 2022 · Completed: Aug 14, 2034
1 condition
1 sponsor
36 locations
NCT05263583
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
PHASE2
Active, not recruiting
14 participants
Started: Dec 9, 2022 · Completed: Jun 30, 2025
9 conditions
1 sponsor
11 locations
NCT05760287
Echocardiographic Characterization of Cardiac Amyloidosis
N/A
Recruiting
255 participants
Started: Dec 9, 2022 · Completed: Feb 2, 2031
1 condition
1 sponsor
1 location
NCT05248802
DLBS2411 Treatment For Functional Dyspepsia
PHASE3
Recruiting
106 participants
Started: Dec 9, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
8 locations
NCT05646680
A Performance Study of (opportunistic) Salpingectomy
NA
Recruiting
200 participants
Started: Dec 9, 2022 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT06297512
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PHASE2
Recruiting
20 participants
Started: Dec 9, 2022 · Completed: Mar 9, 2028
1 condition
1 sponsor
1 location
NCT07042191
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NA
Recruiting
20 participants
Started: Dec 9, 2022 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT05657873
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
PHASE2
Recruiting
68 participants
Started: Dec 9, 2022 · Completed: Dec 9, 2025
5 conditions
1 sponsor
9 locations
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
PHASE3
Recruiting
100 participants
Started: Dec 9, 2022 · Completed: Sep 10, 2028
2 conditions
1 sponsor
60 locations
NCT05634785
CD30 CAR for CD30+ NSGCT
PHASE2
Recruiting
18 participants
Started: Dec 9, 2022 · Completed: Aug 31, 2030
2 conditions
1 sponsor
1 location
NCT05529641
Effects of Diaphragmatic Resistance Training in People with Chronic Neck Pain.
NA
Recruiting
60 participants
Started: Dec 9, 2022 · Completed: Feb 28, 2025
4 conditions
2 sponsors
1 location
NCT05537454
Maternal Stress, Milk Composition, and Preterm Neurodevelopment
N/A
Recruiting
120 participants
Started: Dec 9, 2022 · Completed: Jul 31, 2030
1 condition
1 sponsor
1 location
NCT05434117
Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease
NA
Recruiting
40 participants
Started: Dec 9, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05675332
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
NA
Recruiting
280 participants
Started: Dec 9, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT05394168
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
PHASE1
Active, not recruiting
12 participants
Started: Dec 9, 2022 · Completed: Mar 4, 2025
1 condition
1 sponsor
1 location
NCT05630612
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
PHASE2
Active, not recruiting
32 participants
Started: Dec 8, 2022 · Completed: Sep 1, 2027
3 conditions
2 sponsors
1 location
NCT05638854
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
PHASE1
Recruiting
72 participants
Started: Dec 8, 2022 · Completed: Jul 31, 2025
2 conditions
1 sponsor
2 locations
NCT05513508
The ROTAtional-USE of Interface STUDY
NA
Recruiting
478 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2028
3 conditions
2 sponsors
1 location
NCT05546242
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals
PHASE3
Active, not recruiting
540 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
7 locations
NCT05487391
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
PHASE3
Recruiting
632 participants
Started: Dec 8, 2022 · Completed: May 22, 2029
1 condition
1 sponsor
1 location
NCT06209606
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
EARLY_PHASE1
Recruiting
30 participants
Started: Dec 8, 2022 · Completed: Feb 28, 2029
1 condition
2 sponsors
1 location
NCT05610163
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
PHASE2
Active, not recruiting
783 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2033
3 conditions
2 sponsors
685 locations
NCT05334940
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
N/A
Recruiting
600 participants
Started: Dec 8, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05515536
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
PHASE3
Active, not recruiting
130 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
14 locations
NCT05938478
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
N/A
Recruiting
900 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2035
2 conditions
3 sponsors
1 location
NCT07111884
GMMG Multiple Myeloma Registry
N/A
Recruiting
999 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2027
1 condition
4 sponsors
35 locations
NCT05090033
Characterizing the Use of Ofatumumab in a Real World Setting
N/A
Active, not recruiting
103 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
PHASE1
Active, not recruiting
89 participants
Started: Dec 8, 2022 · Completed: Apr 11, 2027
5 conditions
1 sponsor
26 locations
NCT05559489
Enteral Resuscitation Nepal
PHASE3
Recruiting
240 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05650190
Spectacle Lens Visual Acuity Assessments Study
NA
Active, not recruiting
51 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
6 locations
NCT05501886
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
PHASE3
Recruiting
701 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
217 locations
NCT06847854
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
PHASE1
Recruiting
176 participants
Started: Dec 8, 2022 · Completed: May 30, 2027
1 condition
1 sponsor
35 locations
NCT05492513
Constraint-Induced Movement Therapy for Adults Post-Stroke With Mild Upper Extremity Impairment
NA
Recruiting
12 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT05792631
A Study to Compare Caries Detection in the Pediatric Population Between the iTero Element 5D System and Bitewing Radiographs
NA
Recruiting
70 participants
Started: Dec 8, 2022 · Completed: Jun 1, 2024
2 conditions
1 sponsor
1 location
NCT05650619
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
N/A
Recruiting
300 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05154669
Integrating Financial Coaching and Smoking Cessation Coaching
PHASE3
Recruiting
488 participants
Started: Dec 8, 2022 · Completed: Dec 1, 2027
1 condition
2 sponsors
1 location
NCT05827796
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
70 participants
Started: Dec 8, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05701150
AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
N/A
Recruiting
3,000 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition
4 sponsors
3 locations
NCT05432583
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
PHASE1
Active, not recruiting
318 participants
Started: Dec 8, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
6 locations
NCT05683002
Aronia, Cognition, and Eye Health (ACE)
NA
Recruiting
44 participants
Started: Dec 8, 2022 · Completed: Aug 31, 2024
1 condition
2 sponsors
1 location
NCT05647161
BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)
NA
Active, not recruiting
34 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT05652348
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
N/A
Recruiting
48 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2028
3 conditions
2 sponsors
2 locations
NCT05359211
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
PHASE1
Active, not recruiting
28 participants
Started: Dec 8, 2022 · Completed: Sep 4, 2026
9 conditions
2 sponsors
1 location
NCT04589819
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
PHASE4
Enrolling by invitation
183 participants
Started: Dec 8, 2022 · Completed: Dec 30, 2026
1 condition
4 sponsors
1 location
NCT05658081
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NA
Recruiting
236 participants
Started: Dec 8, 2022 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05112926
Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis
NA
Recruiting
16 participants
Started: Dec 8, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT05266664
Preterm Immune System Development and Response to Immunization
N/A
Recruiting
145 participants
Started: Dec 8, 2022 · Completed: Jul 31, 2026
3 conditions
12 sponsors
7 locations
NCT04756401
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
52 participants
Started: Dec 8, 2022 · Completed: Dec 30, 2027
2 conditions
2 sponsors
4 locations
NCT05596799
Facing Eating Disorder Fears for Anorexia Nervosa
NA
Recruiting
70 participants
Started: Dec 8, 2022 · Completed: Aug 1, 2025
3 conditions
2 sponsors
1 location
NCT05280132
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NA
Recruiting
204 participants
Started: Dec 8, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
1612
1613
1614
1615
1616
1617
1618
More pages
2369
Next